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Background: Each year, approximately 11% of women diagnosed with breast cancer in the United States are 45
years of age or younger. These women have concerns specific to or accentuated by their age, including fertility-
related concerns, and have higher rates of psychosocial distress than women diagnosed at older ages. Current
guidelines recommend that fertility risks be considered early in all treatment plans; however, the extant research
indicates that attention to fertility by the healthcare team is limited. Importantly, attention to fertility may be a proxy
for whether or not other important issues warranting attention in younger women with breast cancer are addressed,
including genetic risks, psychosocial distress, sexual functioning, and body image concerns. The Young & Strong study
tests the efficacy of an intervention designed for young women recently diagnosed with breast cancer and their
oncologists with the intention to: 1) increase attention to fertility as an important surrogate for other issues facing
young women, 2) educate and support young women and their providers, and 3) reduce psychosocial distress
among young women with breast cancer.
Methods/Design: The study employs a cluster randomized design including 14 academic institutions and 40
community sites across the U.S. assigned to either the study intervention arm or contact-time comparison intervention
arm. Academic institutions enroll up to 15 patients per site while community sites enroll up to 10 patients. Patient
eligibility requirements include: an initial diagnosis of stage I-III invasive breast cancer within three months prior,
without a known recurrence or metastatic breast cancer; 18–45 years of age at diagnosis; ability to read and write
in English. The primary outcome is oncologists’ attention to fertility concerns as determined by medical record review.
Secondary outcomes include differences in patient satisfaction with care and psychosocial distress between the two
study arms.
Discussion: Study findings will provide valuable insight into how to increase attention to fertility and other issues
specific to young women with breast cancer and how to improve doctor-patient communication around these issues,
which may promote better quality of care for this population.
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An estimated 232,340 women living in the in the United
States were diagnosed with breast cancer in 2013 [1], ap-
proximately 11% of whom were under the age of 45 [2].
Young women with breast cancer have more aggressive
disease and lower rates of survival than older women
with breast cancer [3]. As a result, this population
usually receives more therapy than women who are diag-
nosed when older (aged 46+) [4,5]. These treatments are
physically and emotionally taxing, particularly given the
lower survival rates for young women. Additionally,
young women with breast cancer face problems unique
to or accentuated by their young age, such as completing
their education, developing a career, and parenting
young children [6]. They are often concerned that their
health care providers have not received adequate train-
ing on health issues specific to their young age, as the
median age at breast cancer diagnosis is 61 [7]. Some
young women may also place high importance on body
image and attractiveness, which can be detrimentally
impacted by cancer treatments. Additionally, younger
women can feel isolated from other breast cancer pa-
tients due to their relative youth [8]. These life factors
and stressors contribute to psychosocial distress, which
is greater in this population than in older women with
breast cancer at both diagnosis and follow-up [9-13].
Due to these multiple unique issues, the Centers for
Disease Control and Prevention has stated that survivor-
ship issues in young breast cancer patients are an import-
ant focus for further research and intervention [14].
In addition to the specific concerns outlined above,
young women diagnosed with breast cancer are of
childbearing age and may desire biologic children. Can-
cer treatments can eliminate or delay fertility in premen-
opausal women [15,16]. Thus, fertility-related concerns
must be addressed early to ensure that opportunities for
fertility preservation are not missed [17,18]. Although
the current recommendation is that fertility risks and
concerns be considered in all treatment plans [17], in
practice, risks to fertility and fertility options may not be
discussed or, if addressed, may be addressed inadequately
[13,19-21]. There are a number of factors that may impair
attention to fertility: providers may be uncomfortable dis-
cussing loss of fertility or may simply forget that this could
be an important topic for the patient, given her life stage;
providers may also lack knowledge about this topic or feel
like they do not have the time to adequately assist patients
in making fertility-related decisions, including decisions
related to fertility preservation methods [22,23].
As well as its direct impact on fertility, attention to
fertility is important because it may be a proxy for
whether or not other issues relevant to younger women
with breast cancer are being addressed, including genetic
risks, psychosocial distress, and sexual functioning. Therehas been increased interest to uniformly include personal-
ized psychosocial support, counseling on genetic risks,
and attention to fertility in treatment plans of young
women with breast cancer [24]. Nonetheless, recent Quality
Oncology Practice Initiative Network audit data determined
that documentation of attention to fertility was less than
30% among the majority of audited practices, and the rate
was 0% in more than 50% of the practices (personal com-
munication between ASCO staff and Dr. Partridge). High
quality care for young women with breast cancer includes
discussing these issues in a systematic and consistent
manner, both at diagnosis and in follow-up. Increased at-
tention to this complement of issues may lead to increased
satisfaction with care and treatment decisions resulting in
decreased distress and better overall quality of life for
young women with breast cancer.
Based on our prior experience with designing a unique
in-clinic program for young women with breast cancer
[25,26], we developed Young & Strong, a print-based
educational and supportive care intervention with a cor-
responding website for young women (18–45 years of
age) newly diagnosed breast cancer and their providers.
The intervention addresses issues salient to this popula-
tion (e.g., body image, child care, fertility, education, and
career issues). We hypothesize that an intervention that
simultaneously increases providers’ awareness of salient
issues and educates and encourages patients to communi-
cate with their doctors about these important topics has
the potential to reduce psychosocial distress and improve
satisfaction with care among young breast cancer patients.
Therefore, the primary aim of the Young & Strong study
is to evaluate the effect of the Young Women’s Interven-
tion (YWI) on oncologists’ attention to fertility issues
compared to a contact-time comparison intervention
focusing on physical activity (PAI). Secondary aims
include exploring how YWI affects attention to other
issues important to young women with breast cancer,
including genetic testing, satisfaction with care, distress,
and quality of life.
Methods
Study design
The Young & Strong study is a multi-site, two arm, cluster
randomized clinical trial with the practice site being the
unit of randomization (see Figure 1). The study compares
the YWI arm to a contact-time, physical activity interven-
tion (PAI) arm. Employing a contact-time comparison
intervention ensures that study results are not a function
of time and attention given to patients due to their
involvement in the study.
Identification of sites
To reach a variety of patients, we are implementing
the study in both academic institutions (n = 14) and
Figure 1 Flow of the young & strong study.
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Figure 2).
Sites were identified in one of three ways. First, key
contacts from national cancer organizations (i.e., National
Cancer Institute Community Cancer Center Program,
American Society of Clinical Oncology (ASCO) Quality
Oncology Practice Initiative Network, and Alliance Cancer
Control Program) sent introductory emails to member
sites describing the study and inviting interested sites to
contact the principal investigator (PI). Second, the PI
directly contacted academic institutions and community
sites across the country serving economically and racially
diverse populations. Third, representatives from interested
sites who learned of the study contacted the study PI
directly.Site participation requirements
Sites have a local PI who ensures that the site adheres to
all study protocols and obtains Institutional Review Board
(IRB) approval. The study is approved by the Dana-Farber
Cancer Institute IRB, which oversees a majority of study
sites via Institutional Authorization Agreements (or Indi-
vidual Investigator Agreements); some sites maintain their
own institutional review. Additionally, sites: a) agree to be
randomized to one of the two intervention arms; b) iden-
tify a site coordinator to manage the study locally; c) ap-
proach eligible patients until recruitment goals are met
or the study stops recruitment, whichever comes first;
d) obtain informed consent from interested patients and
administer the baseline survey on site; e) distribute
intervention materials; f ) assist in follow-up of study
Figure 2 Location of sites participating in the Young & Strong study.
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study participants to the lead site for review; h) facili-
tate medical oncology provider interaction with the
intervention and study including alerting them of a
patient’s enrollment and encouraging them to complete
a one-time survey regarding the intervention.Lead site and participating site responsibilities
Lead site
The lead study site, a comprehensive cancer center
located in the Northeastern part of the United States, is
responsible for setting up all subcontracts and for train-
ing key staff at each participating site by telephone. After
completion of this training, sites begin recruiting partici-
pants. Staff at the lead site conduct regular check-in calls
during recruitment and beyond as needed and ensure
that sites receive needed intervention materials.Participating sites
Site coordinators identify eligible patients by reviewing
new patient lists or through other usual recruitment
procedures. Patients are eligible to participate if they are:
a) within three months of initial diagnosis of stage I-III
invasive breast cancer, without a known recurrence or
metastatic breast cancer; b) 18–45 years of age at time
of diagnosis; c) able to read and write in English. Add-
itionally, patients must have their first apppointment
with an oncologist particpating in the study after the site
has completed the telephone training.
At each site, the site coordinator or other staff (e.g., re-
search nurses) approaches eligible patients to discuss andexplain study requirements. They obtain signed informed
consent and then distribute the self-administered baseline
survey to consented patients. Once the baseline survey is
complete, the patient receives the intervention materials
(described below). A copy of the enrollment materials, in-
cluding consent form and baseline survey, are transmitted
to the lead site where study staff officially registers the
patient with the lead site’s registering board.Overview of the interventions
There is considerable work conducted across a range of
intervention topics demonstrating that patient-oriented
interventions, without parallel provider or systems-level
interventions, are neither well-implemented nor sus-
tained [27-29]. Thus, we designed a multi-pronged inter-
vention, with both provider and patient intervention
components.
The YWI focuses on issues important to young women
newly diagnosed with breast cancer, including fertility and
early menopause, pregnancy after breast cancer, psycho-
social concerns (e.g., coping with anxiety, dating, career
and education issues, and dealing with young children),
genetic issues, body image, and sexual functioning. The
physical activity intervention (PAI), developed for this
study, is a contact-time comparison intervention designed
to promote physical activity. Physical activity was selected
as the focus of the contact-time comparison intervention
due to the known benefits of physical activity for people
with cancer, not unique to young women, including:
improved cardiovascular fitness, quality of life, and self-
esteem [30]; reduced depression, anxiety, and tiredness;
Figure 3 Cover of the booklet for the young women’s
intervention (YWI).
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survival [31].
Intervention development
To inform the design of intervention materials, we
conducted four focus groups with young breast cancer
survivors in Boston, Massachusetts (n = 36) [32] and key
informant interviews (n = 20) with a racially, ethnically,
and geographically diverse sample of young women with
a history of breast cancer [33]. In addition, throughout
intervention development, young breast cancer survivors
and patient advocates reviewed intervention materials to
ensure that all salient concerns were addressed. Once
the intervention materials were developed, they were
piloted at the lead site (MA) and three community sites




All intervention materials include key information
designed to provide education and increase participants’
self-efficacy to discuss fertility/physical activity (arm spe-
cific) with their oncologists. The content of the interven-
tion materials are specific to each arm (YWI vs. PAI) but
include similar components: 1) a print booklet, the
primary intervention component, 2) baseline/follow-up
doctor visit checklists to encourage patients to discuss
fertility/physical activity with their oncologists, and 3) a
study-specific website that encompasses all of the infor-
mation in the booklet plus additional information
and resources, such as videos and downloadable PDFs
(See Figures 3, 4 and 5). Materials are designed to be
sustainable and disseminable. While the booklet, check-
lists, and website are specific to the intervention (YWI
or PAI), and therefore hold distinct information, both
sets of materials include information about the import-
ance of social support and give pointed information
about general healthy living topics, such as diet and
nutrition and alcohol consumption. Participants receive
intervention materials and login information for the
website after consenting and completing the baseline
assessment.
Oncologist materials
Intervention materials developed for oncologists include
an introductory letter outlining the goals of the study,
procedures, and their role; the arm-specific patient
materials; clinical checklists which parallel the patient
checklists so that topics can be discussed at baseline and
follow-up appointments; and access to the website, with
a special tab only accessible to clinicians. This tab holds
videos by leading researchers in the field discussing the
importance of addressing fertility or physical activity(dependent on study arm), additional oncologist- specific
materials such as medical text related to the specific
topic areas, and downloadable PDFs of the checklists.
PDFs of the checklists. The study also provided email ac-
cess to medical experts for consultation in young women’s
issues and exercise among breast cancer patients.
Statistical design
The number of sites (14 academic institutions and 40
community sites) and the sample size at each site (up to
15 participants per academic institution, up to 10 partic-
ipants per community site) were chosen to detect differ-
ences in attention to fertility at three months. We based
our expected detection difference on the 2009 data from
the Quality Oncology Practice Initiative Network. These
data, from 156 practices, showed that only 30% of records
reflected documentation of discussion about infertility
risks prior to treatment with patients of reproductive age
and nearly half of practices had a 0% rate of documenta-
tion of discussion of fertility risks or concerns. Compli-
ance with this quality of care measure, discussion of
fertility, has not substantially improved since the Spring
2009 evaluation (personal communication between ASCO
staff and Dr. Partridge). Therefore, we estimate that
among study participants who are seen at sites assigned to
Figure 4 Baseline checklist for patients in the young women’s intervention (YWI).
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10% and that the rate among sites randomized the YWI
arm will be at least 40%. The sample size was selected to
give adequate power to detect a difference of around
30% in attention to fertility at three months. As there
are no data on within-practice correlation and practice
size, we assumed a practice size of at least 15 within large
academic sites and at least five within small community
sites and a within-practice correlation of 0.50 to estimate
power. With seven practices per arm from large academic
sites and 20 practices per arm from small community sites
(total of a minimum of 410 patients accrued at 54 sites),
there is 80% power to detect a difference of 28%. Using
calculations proposed by Donner and Buck [34], we have
90% power to detect the same difference if the within-
practice correlation is 0.30.Measures
Attention to fertility as reported in medical records
The primary study outcome, attention to fertility within
three months of their enrollment into the study will be
assessed by medical record review. Medical record
extractors, who will be blind to intervention arm, will
determine whether the medical records include agreed
upon notations indicating that fertility was addressed
and will note the timing of these discussions with respect
to diagnosis and treatment. Using a pre-populated list,
they will note if fertility issues did not need to be discussed
(i.e., patient had a bilateral oophorectomy prior to diagno-
sis). Reporting will be done in aggregate. We will also
record additional items, including documentation of
referral to genetic testing, discussion of contraception
use, and attention to weight and exercise behaviors.
Figure 5 Screen shot from the young women’s intervention (YWI) website.
Greaney et al. BMC Public Health  (2015) 15:37 Page 7 of 11Participant surveys
Participants complete an initial baseline assessment and
additional assessments at three, six, and twelve months
post-enrollment. As an incentive, study participants re-
ceive a $10, $15, and $20 gift card for each follow-up as-
sessment, respectively. To reduce participant burden, not
all measures (see below) are assessed at each time point
(Table 1). Patients primarily complete the follow-up sur-
veys via a HIPAA compliant website or by telephone, with
participants choosing their preferred modality. Patients
are also able to complete follow-up surveys at clinic ap-
pointments if more convenient. Or, if participants express
a preference to return completed surveys via mail, they
may do so. Providers complete one five-minute survey,
approximately two weeks after his/her first patient enrolls
on the study. Each participating site receives $200 for each
enrolled study participant to help cover administrative
costs.
Attention to fertility as reported by patients
On all follow-up surveys, study participants complete
the Fertility Issues Survey that was developed for
premenopausal women undergoing treatment for early
stage breast cancer, and assesses concern about fertility,impact of fertility issues on treatment decision-making,
perceived risk of infertility following treatment, fertility
history, and desire for future pregnancies [35]. Current
contraception use is being assessed using a measure de-
signed for an ongoing cohort study of young women
with breast cancer [36].
Self-reported anxiety, depression and distress
Participants’ level of anxiety and depression are measured
by the Hospital Anxiety and Depression Scale (HADS)
[37], which is both reliable and valid [38]. A score of 11 or
greater indicates a possible need for intervention. In
addition, participants’ level of depressive symptomology in
the preceding week will be assessed by the Center for Epi-
demiologic Studies Depression Scale (CES-D) [39]. The
CES-D provides a summary score for level of depressive
symptoms, with score ranges from 0–60. Scores > 16 indi-
cate potentially clinically significant levels of depression.
Participants also complete the Perceived Stress Scale
(PSS) to assess the perceived level of stress in their lives in
the preceding month. The PSS was designed to determine
how unpredictable, uncontrollable, and overloaded re-
spondents find their lives and also measure their current
levels of experienced stress [40]. We are using the HADS
Table 1 Measures and time of assessment in the young & strong study
Measure Assessed by Time of assessment
Attention to fertility
• Medical Record Review 3- and 6-mo
• Fertility Issues Survey [35] 3-, 6- and 12-mo
Anxiety, depression, and distress
• Hospital Anxiety and Depression Scale (HADS) [37] BL, 3- and 12-mo
• Center for Epidemiologic Studies Depression Scale (CES-D) [39] BL, 3- and 12-mo
• Perceived Stress Scale (PSS) [40] BL, 3- and 12-mo
Health-related quality of life
• Cancer Rehabilitation Evaluation System-SF (CARES-SF) [41,42] 3- and 12-mo
Contraception
• Items used in prior work assessing methods of contraceptive use among
young women with breast cancer at diagnosis and over time [36].
3- and 12-mo
Satisfaction with care
• Short-Form Patient Satisfaction Questionnaire (PSQ-18) [43] 3-mo
Physical activity
• Godin Leisure Time Physical Activity Questionnaire [44,45] BL, 3-, 6- and 12-mo
• Nurse’s Health Study Physical Activity Question Index [46] BL, 12-mo
Intervention engagement
• Items used in prior work to gauge use of intervention materials [49] 3-mo
Socio-demographics
• United States Department of Health and Human Services Breast Cancer Core
Questionnaire to assess age ethnicity, education, marital status, employment
status [47,48]
BL
• Participants’ perceived financial status of their household
• Ashkenazi ancestry
Note: BL = baseline.
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that we have used extensively in other studies with young
women with breast cancer. We are using both the CES-D
and PSS because these scales are more sensitive than the
HADS to potential changes in depression and stress, re-
spectively. While all measures (HADS, CES-D, and PSS)
will be used in the data analysis, only the HADS will be
used to immediately assess depressive symptoms in partic-
ipants in order to notify their physician, as needed.
Health-related quality of life
Patients complete a modified version of the 59-item
Cancer Rehabilitation Evaluation System-Short Form
(CARES-SF) to evaluate health-related quality of life and
concerns more specific to cancer survivorship [41,42].
Additionally, participants complete three scales from the
long CARES: sexual interest, sexual dysfunction, and
body image.
Satisfaction with care
Participants complete the Short-Form Patient Satisfac-
tion Questionnaire (PSQ-18), an 18-item scale withseven subscales, including general satisfaction, technical
quality, interpersonal manner, communication, financial
aspects, time spent with doctor, and accessibility and
convenience [43]. Additionally, participants report on
provider attention to emotional health.Physical activity
Patients complete the Godin Leisure-Time Physical Activ-
ity Questionnaire [44,45], which has been modified to
include the average duration of activities at baseline and
three, six, and 12-months post-enrollment. This question-
naire will be used to estimate weekly minutes of moderate
and vigorous activity physical activity, with time spent in
moderate physical activity being the primary outcome.
Weekly minutes of vigorous activity and average weekly
frequency of mild, moderate, and strenuous intensity exer-
cise will also be examined to evaluate change in physical
activity behaviors. Additionally, at baseline and 12-months
post-enrollment, participants will complete the Nurse’s
Health Study Physical Activity Question Index [46], which
asks about the average time a person spent doing specific
Greaney et al. BMC Public Health  (2015) 15:37 Page 9 of 11recreational activities in a typical week during the past
year.
Socio-demographics characteristics
As part of the baseline survey, participants complete items
in the Sociocultural Module of the United States Depart-
ment of Health and Human Services Breast Cancer Core
Questionnaire to assess age, ethnicity, education level,
marital status, employment status, and income [47,48]. A
participant’s perceived financial status of her household
also was assessed, as was presence of Ashkenazi ancestry.
Intervention engagement
At three months post-enrollment, participants report the
time they spent with the intervention materials, their en-
gagement with the materials, their attention to the inter-
vention messages, and the salience of the messages for
them [49]. Salience will be measured by rating partici-
pants’ degree of interest in the intervention messages
and how personally relevant the messages were. While
the booklet is the primary intervention component, we
will collect aggregate data on website usage. These data
will provide valuable insight into the use of intervention
components that will inform future interventions and
research.
Planned analyses
For the primary outcome, attention to fertility, the YWI
and PAI will be compared in terms of attention to fertility
issues as reported in the medical records using general
estimating equations (GEE) to evaluate binomial propor-
tions with clustered binary data [50]. GEEs will include
terms for treatment arm and stratum, and population-
averaged contrasts will be used to test the effects of the
YWI versus PAI on attention to fertility. Generalized lin-
ear mixed models (GLMMs) will be used in subsequent
analyses to describe the effect of the YWI with practice in-
corporated as a random effect, accounting for covariates
such as patient demographics and, if appropriate, includ-
ing variables in the secondary analyses as well as practice-
level characteristics such as setting (urban, suburban,
rural) and size of practice. Similar analyses will be con-
ducted using attention to fertility as reported by patients.
All analyses will be based on the intent-to-treat (ITT)
population, consisting of all subjects at all randomized
sites.
For the secondary analyses, examining the effect of the
YWI on patients’ emotional health, distress, and quality of
life, we will estimate proportions within each arm for each
measure and report 95% confidence intervals. Lastly, to
examine the effects of the PAI on improvement and main-
tenance of exercise behaviors, we will determine the mean
change in exercise time at three months (post – pre) using
a 2-sample t-test adjusting for within-practice correlationfor both the PAI and YWI. We will examine change in
exercise behaviors at six and twelve months to evaluate
maintenance.
Discussion
The Young & Strong study is designed to address the
well-documented lack of attention to an important issue,
fertility concerns, among a unique and relatively uncom-
mon cancer population, young women with breast cancer.
This study has been carefully designed to evaluate the role
of a novel intervention, YWI, to improve targeted out-
comes in young women with breast cancer and for dis-
semination in the future if it is successful. The use of a
salient contact-time control intervention allows us to
offer educational materials to providers and patients to
engage them in the control content while at the same time
not likely interfering with the main outcome of the inter-
vention, attention to fertility. The use of a cluster ran-
domized controlled trial, randomized by site, minimizes
contamination between the intervention arm and the
control arm that could result from provider- and site-
level knowledge of the educational materials in both
arms. We chose to develop an intervention for both
patients and providers as we believe it is critical for
both groups to engage in these discussions early in the
course of treatment decision-making. The intervention
is designed to be sustainable and disseminable; thus, if
effective, we will work with an expanded network of
provider organizations to disseminate the intervention
to providers and patients. We believe that this is the
first study to look at the rates of discussion of these
topics between patients and providers while simultan-
eously intending to increase the discussion of these topics.
This study is also further distinguished by the expansive
reach into a variety of clinics across the country.
We believe that study findings will provide valuable
insight into how to increase attention to fertility and other
issues specific to young women with breast cancer and
how to improve doctor-patient communication around
these issues, which may promote better quality of care for
this population. This work will add to the literature about
how to improve care for young women with breast cancer,
as well as serve as a novel model to improve care and
overcome barriers to delivering optimal care for other
unique groups of patients.
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